Axoplasmic transport blockage therapy in herpes zoster ophthalmicus
- PMID: 92895
- DOI: 10.1007/BF02387423
Axoplasmic transport blockage therapy in herpes zoster ophthalmicus
Abstract
Three patients with herpes zoster ophthalmicus were treated with an oral administration of colchicine and corticosteroid, while another seven were given systemic corticosteroid, vitamins, and sedatives. Colchicine inhibited the formation of new skin lesions but did not suppress the already grown vesicles. The effect of colchicine was attributed to a blockage of intra-axonal dissemination by neurotrophic virus.
Similar articles
-
[Herpes zoster keratoendotheliitis].Yan Ke Xue Bao. 1994 Dec;10(4):248-50. Yan Ke Xue Bao. 1994. PMID: 7774702 Clinical Trial. Chinese.
-
High-dose oral acyclovir in acute herpes zoster ophthalmicus: the end of the corticosteroid era.Curr Eye Res. 1991;10 Suppl:171-5. doi: 10.3109/02713689109020375. Curr Eye Res. 1991. PMID: 1864091
-
Editorial: Herpes zoster ophthalmicus treated with cytarabine.Med J Aust. 1973 Nov 24;2(21):956. doi: 10.5694/j.1326-5377.1973.tb129859.x. Med J Aust. 1973. PMID: 4543929 No abstract available.
-
The varicella-zoster virus: systemic and ocular features.J Am Acad Dermatol. 1984 Aug;11(2 Pt 1):165-91. doi: 10.1016/s0190-9622(84)70148-4. J Am Acad Dermatol. 1984. PMID: 6090512 Review.
-
Herpes Zoster Ophthalmicus.Prim Care. 2015 Sep;42(3):285-303. doi: 10.1016/j.pop.2015.05.007. Prim Care. 2015. PMID: 26319339 Review.